The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans.
Small-cap U.S. healthcare stocks have experienced severe downward pressure over the past six months, with several names ...
Explore how oncology data season is drawing attention to Nuvation Bio, Arcus Biosciences, and smaller cancer-focused biotech ...
Climb Bio Inc (NASDAQ:CLYM) is one of the best performing small cap stocks so far in 2026. Oppenheimer lifted the price target on Climb Bio Inc (NASDAQ:CLYM) to $18 from $10 on April 12, maintaining ...
Zacks Small Cap Research on MSN
PBSV is a small stock worth a look
By Brad Sorensen, CFA OTCQB: PBSV READ THE FULL PBSV RESEARCH REPORT Tucked away on the OTCQB, Pharma-Bio Serv, Inc. (OTCQB: PBSV) is the kind of company that rarely attracts headlines but ...
Small-cap investors are convinced the stock-market tide has turned in their favor Small-cap stocks are off to a strong start in 2026. But investors shouldn't get carried away just yet. Small-cap's ...
Stocktwits on MSN
PASG stock slumps 16% after-hours — what’s driving the selloff?
Under the deal, Remix will become the surviving company and operate as Remix Therapeutics, with Passage Bio shareholders receiving a small stake in the combined entity. ・The transaction is structured ...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 8, Chardan reiterated Iovance Biotherapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results